Hi guys,
As I have been saying with my previous posts Relenza is going to be THE ONLY ANTIVIRAL drug currently in the market to help fighting certain strains of flu and the almighty birdflu.
The writing is on the wall and the latest announcement from GSK sending more Relenza to Japan underwrites this sentiment.
Tamiflu will soon be history and Relenza the drug of choice fighting certain flu strains.
So good to see that this drug still get its place in history before the patent runs out, and it will be able to make some real good money for the next 5 years.
Still not to late to jump into Biota not only for Relenza but for Lani and the other blockbuster drugs in the pipe line.
jojo
- Forums
- ASX - By Stock
- BTA
- Ann: GSK imports additional Relenza to Japan
Ann: GSK imports additional Relenza to Japan , page-8
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online